FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308654097> ?p ?o ?g. }

• W4308654097 endingPage "e0275381" @default.
• W4308654097 startingPage "e0275381" @default.
• W4308654097 abstract "One of the stages of reproduction of SARS-CoV-2 is the S-protein glycosylation to facilitate penetration into target cells. It has been suggested that SARS-CoV-2 is able to enter erythrocytes, interact with heme and porphyrin, which could influence HbA1c levels. Assessment of HbA1c levels in individuals with acute COVID-19 and after recovery may show clinical relevance of this hypothesis.To assess HbA1c levels in patients with COVID-19 in the acute phase and in early (6-8 weeks) and late (52±2 weeks) periods after recovery.We conducted a multicenter prospective study, which included patients hospitalized in Endocrinology Research Centre and the City Clinical Hospital № 52 diagnosed with COVID-19, virus identified/ not identified. Patients were divided into three groups according to baseline HbA1c level and the presence or absence of previous history of diabetes previous history of diabetes mellitus (DM): HbA1c ≤ 6.0%, HbA1c > 6.0% and patients with DM. Patients were examined during the acute COVID-19 phase and in early (6-8 weeks) and late (52±2 weeks) periods after recovery. Oral glucose tolerance test was performed in the group with initial HbA1c > 6.0% to clarify the diagnosis.We included 194 patients in the study. During the follow-up, 52 patients were examined in 6-8 week period: 7 with HbA1c ≤ 6.0%, 34 with HbA1c > 6.0%, 11-with previously diagnosed DM. Carbohydrate metabolism assessment in the later stages (52±2 weeks) after recovery was performed in 78 patients: 33 patients with HbA1c ≤ 6.0%, 36 patients with HbA1c > 6.0% and 9 patients with previously established diabetes. HbA1c median in patients with HbA1c ≤ 6.0% was 5.7% [5.3;5.8], with HbA1c>6.0% -6.4% [6.2; 6.6], with previously diagnosed DM-7.7% [7.2; 8.9]. Statistically significant decrease in HbA1c over time 6-8 weeks after extracts were obtained in both groups of individuals without a history of DM (Wilcoxon test, p<0.05). After 52±2 weeks we observed HbA1c decrease in all three groups (Fridman test, p<0.05): in patients with HbA1c ≤ 6.0% median HbA1c was 5.5[5.3;5.7], with HbA1c>6.0% - 6.1[6.15;6.54], with previously diagnosed DM-7.8 [5.83; 8.08]. Development of DM after 52±2 weeks was recorded in 7.24% of all examined patients without a history of DM, which is 16.6% of the total number of patients examined in dynamics with HbA1c > 6.0%.HbA1c elevation during the acute phase of COVID-19 may be false due to the effect of SARS-CoV-2 on hemoglobin kinetics and/or detection on the surface of the SARS-CoV-2 virion highly glycosylated S-proteins by high performance liquid chromatography determinations. Upon detection HbA1c > 6.0% in patients with COVID-19 in the active phase of the disease without concomitant hyperglycemia re-determine the level of HbA1c after recovery is recommended." @default.
• W4308654097 created "2022-11-13" @default.
• W4308654097 creator A5031991351 @default.
• W4308654097 creator A5044242938 @default.
• W4308654097 creator A5049480035 @default.
• W4308654097 creator A5054372499 @default.
• W4308654097 creator A5057812292 @default.
• W4308654097 creator A5063060582 @default.
• W4308654097 creator A5084734229 @default.
• W4308654097 date "2022-11-09" @default.
• W4308654097 modified "2023-09-26" @default.
• W4308654097 title "Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital" @default.
• W4308654097 cites W1980564592 @default.
• W4308654097 cites W2013665941 @default.
• W4308654097 cites W2013861903 @default.
• W4308654097 cites W2050583714 @default.
• W4308654097 cites W2085007085 @default.
• W4308654097 cites W2097912644 @default.
• W4308654097 cites W2144913975 @default.
• W4308654097 cites W2155628089 @default.
• W4308654097 cites W2895479306 @default.
• W4308654097 cites W3009912996 @default.
• W4308654097 cites W3020720269 @default.
• W4308654097 cites W3022646285 @default.
• W4308654097 cites W3025089998 @default.
• W4308654097 cites W3025528269 @default.
• W4308654097 cites W3028537052 @default.
• W4308654097 cites W3034475813 @default.
• W4308654097 cites W3034994496 @default.
• W4308654097 cites W3037810226 @default.
• W4308654097 cites W3039292153 @default.
• W4308654097 cites W3039509428 @default.
• W4308654097 cites W3042693827 @default.
• W4308654097 cites W3080555361 @default.
• W4308654097 cites W3093613671 @default.
• W4308654097 cites W3095822337 @default.
• W4308654097 cites W3103207834 @default.
• W4308654097 cites W3106995227 @default.
• W4308654097 cites W3112745632 @default.
• W4308654097 cites W3157222910 @default.
• W4308654097 cites W3157994357 @default.
• W4308654097 cites W3185153595 @default.
• W4308654097 cites W4200344989 @default.
• W4308654097 cites W4221000027 @default.
• W4308654097 cites W4223898222 @default.
• W4308654097 cites W4239939355 @default.
• W4308654097 cites W4288085727 @default.
• W4308654097 doi "https://doi.org/10.1371/journal.pone.0275381" @default.
• W4308654097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36350895" @default.
• W4308654097 hasPublicationYear "2022" @default.
• W4308654097 type Work @default.
• W4308654097 citedByCount "1" @default.
• W4308654097 countsByYear W43086540972023 @default.
• W4308654097 crossrefType "journal-article" @default.
• W4308654097 hasAuthorship W4308654097A5031991351 @default.
• W4308654097 hasAuthorship W4308654097A5044242938 @default.
• W4308654097 hasAuthorship W4308654097A5049480035 @default.
• W4308654097 hasAuthorship W4308654097A5054372499 @default.
• W4308654097 hasAuthorship W4308654097A5057812292 @default.
• W4308654097 hasAuthorship W4308654097A5063060582 @default.
• W4308654097 hasAuthorship W4308654097A5084734229 @default.
• W4308654097 hasBestOaLocation W43086540971 @default.
• W4308654097 hasConcept C126322002 @default.
• W4308654097 hasConcept C134018914 @default.
• W4308654097 hasConcept C188816634 @default.
• W4308654097 hasConcept C205545832 @default.
• W4308654097 hasConcept C2777180221 @default.
• W4308654097 hasConcept C2777538456 @default.
• W4308654097 hasConcept C2779134260 @default.
• W4308654097 hasConcept C2909938374 @default.
• W4308654097 hasConcept C3008058167 @default.
• W4308654097 hasConcept C524204448 @default.
• W4308654097 hasConcept C555293320 @default.
• W4308654097 hasConcept C71924100 @default.
• W4308654097 hasConceptScore W4308654097C126322002 @default.
• W4308654097 hasConceptScore W4308654097C134018914 @default.
• W4308654097 hasConceptScore W4308654097C188816634 @default.
• W4308654097 hasConceptScore W4308654097C205545832 @default.
• W4308654097 hasConceptScore W4308654097C2777180221 @default.
• W4308654097 hasConceptScore W4308654097C2777538456 @default.
• W4308654097 hasConceptScore W4308654097C2779134260 @default.
• W4308654097 hasConceptScore W4308654097C2909938374 @default.
• W4308654097 hasConceptScore W4308654097C3008058167 @default.
• W4308654097 hasConceptScore W4308654097C524204448 @default.
• W4308654097 hasConceptScore W4308654097C555293320 @default.
• W4308654097 hasConceptScore W4308654097C71924100 @default.
• W4308654097 hasFunder F4320321912 @default.
• W4308654097 hasIssue "11" @default.
• W4308654097 hasLocation W43086540971 @default.
• W4308654097 hasLocation W43086540972 @default.
• W4308654097 hasLocation W43086540973 @default.
• W4308654097 hasOpenAccess W4308654097 @default.
• W4308654097 hasPrimaryLocation W43086540971 @default.
• W4308654097 hasRelatedWork W110977339 @default.
• W4308654097 hasRelatedWork W2031287108 @default.
• W4308654097 hasRelatedWork W2078820150 @default.
• W4308654097 hasRelatedWork W2128979963 @default.
• W4308654097 hasRelatedWork W2146318253 @default.

• next